- Home
- CMBM vs INKT Comparison
CMBM vs INKT Comparison
Compare CMBM & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- INKT
- Stock Information
- Founded
- CMBM 2011
- INKT 2017
- Country
- CMBM United States
- INKT United States
- Employees
- CMBM N/A
- INKT N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- INKT Medicinal Chemicals and Botanical Products
- Sector
- CMBM Technology
- INKT Health Care
- Exchange
- CMBM Nasdaq
- INKT Nasdaq
- Market Cap
- CMBM 39.5M
- INKT 36.7M
- IPO Year
- CMBM 2019
- INKT 2021
- Fundamental
- Price
- CMBM $1.06
- INKT $10.10
- Analyst Decision
- CMBM Strong Buy
- INKT Strong Buy
- Analyst Count
- CMBM 3
- INKT 2
- Target Price
- CMBM $5.50
- INKT $6.50
- AVG Volume (30 Days)
- CMBM 189.7K
- INKT 70.0K
- Earning Date
- CMBM 03-04-2025
- INKT 03-20-2025
- Dividend Yield
- CMBM N/A
- INKT N/A
- EPS Growth
- CMBM N/A
- INKT N/A
- EPS
- CMBM N/A
- INKT N/A
- Revenue
- CMBM $172,215,000.00
- INKT N/A
- Revenue This Year
- CMBM N/A
- INKT N/A
- Revenue Next Year
- CMBM $16.49
- INKT N/A
- P/E Ratio
- CMBM N/A
- INKT N/A
- Revenue Growth
- CMBM N/A
- INKT N/A
- 52 Week Low
- CMBM $0.64
- INKT $4.56
- 52 Week High
- CMBM $4.92
- INKT $19.00
- Technical
- Relative Strength Index (RSI)
- CMBM 42.27
- INKT 54.73
- Support Level
- CMBM $1.05
- INKT $8.97
- Resistance Level
- CMBM $1.69
- INKT $9.98
- Average True Range (ATR)
- CMBM 0.15
- INKT 1.44
- MACD
- CMBM -0.04
- INKT -0.07
- Stochastic Oscillator
- CMBM 8.19
- INKT 42.97
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.